We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF

20 hedge funds and large institutions have $8.2M invested in Invesco NASDAQ Biotechnology ETF in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

24% more capital invested

Capital invested by funds: $6.61M → $8.2M (+$1.58M)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

5% more funds holding

Funds holding: 1920 (+1)

3.73% more ownership

Funds ownership: 17.89%21.62% (+3.7%)

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IBBQ Hedge Fund Activity: Q3 2025 in Review

20 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2025, worth a combined $8.2M — up 24% from $6.61M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IBBQ positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was GeoWealth Management, opening a new position worth an estimated $427K. The largest seller was Atria Investments, exiting entirely with an estimated $211K sold.

  • 20 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2025, up from 19 in Q2 2025.
  • Funds reported $8.2M of Invesco NASDAQ Biotechnology ETF stock for Q3 2025, up 24% quarter-over-quarter.
  • 6 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2025 and 5 closed out, a net change of +1 holder.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2025 was GeoWealth Management, an estimated $427K added.
  • The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2025 was Atria Investments, an estimated $211K sold.

Based on aggregated 13F filings for Q3 2025.